Annual EBIT
$54.64 M
+$13.12 M+31.59%
31 December 2023
Summary:
Core Laboratories NV annual earnings before interest & taxes is currently $54.64 million, with the most recent change of +$13.12 million (+31.59%) on 31 December 2023. During the last 3 years, it has risen by +$131.44 million (+171.14%). CLB annual EBIT is now -84.23% below its all-time high of $373.23 million.CLB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$19.80 M
+$3.79 M+23.71%
30 September 2024
Summary:
Core Laboratories NV quarterly earnings before interest & taxes is currently $19.80 million, with the most recent change of +$3.79 million (+23.71%) on 30 September 2024. Over the past year, it has increased by +$5.13 million (+34.97%). CLB quarterly EBIT is now -78.11% below its all-time high of $90.45 million, reached on 31 December 2014.CLB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$58.96 M
+$5.13 M+9.53%
30 September 2024
Summary:
Core Laboratories NV TTM earnings before interest & taxes is currently $58.96 million, with the most recent change of +$5.13 million (+9.53%) on 30 September 2024. Over the past year, it has increased by +$3.29 million (+5.90%). CLB TTM EBIT is now -82.98% below its all-time high of $346.53 million, reached on 31 December 2014.CLB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.6% | +35.0% | +5.9% |
| 3 y3 years | +171.1% | +198.2% | +8.3% |
| 5 y5 years | -53.9% | -36.5% | -37.0% |
CLB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +171.1% | at high | +5164.7% | at high | +83.7% |
| 5 y | 5 years | -53.9% | +171.1% | -36.5% | +118.2% | -39.0% | +174.5% |
| alltime | all time | -84.2% | +171.1% | -78.1% | +118.2% | -83.0% | +174.5% |
Core Laboratories NV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.80 M(+23.7%) | $58.96 M(+9.5%) |
| June 2024 | - | $16.01 M(+86.8%) | $53.83 M(-5.1%) |
| Mar 2024 | - | $8.57 M(-41.2%) | $56.73 M(+3.8%) |
| Dec 2023 | $54.64 M(+31.6%) | $14.58 M(-0.6%) | $54.64 M(-1.9%) |
| Sept 2023 | - | $14.67 M(-22.4%) | $55.68 M(+0.0%) |
| June 2023 | - | $18.91 M(+191.7%) | $55.65 M(+15.0%) |
| Mar 2023 | - | $6.48 M(-58.5%) | $48.40 M(+16.5%) |
| Dec 2022 | $41.52 M(-8.3%) | $15.62 M(+6.6%) | $41.52 M(+3.5%) |
| Sept 2022 | - | $14.64 M(+25.7%) | $40.11 M(+24.9%) |
| June 2022 | - | $11.65 M(-3080.1%) | $32.10 M(-3.5%) |
| Mar 2022 | - | -$391.00 K(-102.8%) | $33.25 M(-26.5%) |
| Dec 2021 | $45.26 M(-158.9%) | $14.20 M(+113.9%) | $45.26 M(-16.9%) |
| Sept 2021 | - | $6.64 M(-48.1%) | $54.47 M(-7.9%) |
| June 2021 | - | $12.80 M(+10.1%) | $59.16 M(+35.1%) |
| Mar 2021 | - | $11.62 M(-50.3%) | $43.79 M(-157.0%) |
| Dec 2020 | -$76.81 M(-179.4%) | $23.40 M(+106.5%) | -$76.81 M(-3.0%) |
| Sept 2020 | - | $11.33 M(-541.4%) | -$79.15 M(+33.5%) |
| June 2020 | - | -$2.57 M(-97.6%) | -$59.28 M(+106.5%) |
| Mar 2020 | - | -$108.97 M(-617.6%) | -$28.70 M(-129.7%) |
| Dec 2019 | $96.68 M(-18.5%) | $21.05 M(-32.5%) | $96.68 M(+3.3%) |
| Sept 2019 | - | $31.21 M(+11.4%) | $93.61 M(-3.8%) |
| June 2019 | - | $28.01 M(+70.6%) | $97.28 M(-5.3%) |
| Mar 2019 | - | $16.41 M(-8.7%) | $102.72 M(-13.4%) |
| Dec 2018 | $118.62 M(+7.9%) | $17.98 M(-48.5%) | $118.62 M(-10.8%) |
| Sept 2018 | - | $34.88 M(+4.3%) | $133.05 M(+6.6%) |
| June 2018 | - | $33.45 M(+3.5%) | $124.84 M(+5.1%) |
| Mar 2018 | - | $32.32 M(-0.3%) | $118.75 M(+8.0%) |
| Dec 2017 | $109.97 M(+25.7%) | $32.41 M(+21.5%) | $109.97 M(+9.6%) |
| Sept 2017 | - | $26.67 M(-2.5%) | $100.36 M(+5.4%) |
| June 2017 | - | $27.36 M(+16.2%) | $95.18 M(+8.1%) |
| Mar 2017 | - | $23.54 M(+3.3%) | $88.05 M(+0.7%) |
| Dec 2016 | $87.45 M(-45.7%) | $22.80 M(+6.1%) | $87.45 M(-1.0%) |
| Sept 2016 | - | $21.49 M(+6.2%) | $88.30 M(-22.3%) |
| June 2016 | - | $20.23 M(-11.8%) | $113.63 M(-19.6%) |
| Mar 2016 | - | $22.94 M(-3.0%) | $141.29 M(-12.3%) |
| Dec 2015 | $161.07 M(-53.5%) | $23.64 M(-49.5%) | $161.07 M(-29.3%) |
| Sept 2015 | - | $46.82 M(-2.2%) | $227.88 M(-15.7%) |
| June 2015 | - | $47.89 M(+12.1%) | $270.18 M(-11.8%) |
| Mar 2015 | - | $42.72 M(-52.8%) | $306.42 M(-11.6%) |
| Dec 2014 | $346.53 M(+3.9%) | $90.45 M(+1.5%) | $346.53 M(+0.7%) |
| Sept 2014 | - | $89.12 M(+5.9%) | $344.00 M(+1.3%) |
| June 2014 | - | $84.13 M(+1.6%) | $339.47 M(+0.7%) |
| Mar 2014 | - | $82.83 M(-5.8%) | $337.21 M(+1.1%) |
| Dec 2013 | $333.42 M(+12.2%) | $87.92 M(+3.9%) | $333.42 M(+3.7%) |
| Sept 2013 | - | $84.60 M(+3.3%) | $321.37 M(+3.0%) |
| June 2013 | - | $81.87 M(+3.6%) | $312.15 M(+3.2%) |
| Mar 2013 | - | $79.04 M(+4.2%) | $302.41 M(+1.7%) |
| Dec 2012 | $297.28 M(+19.0%) | $75.87 M(+0.6%) | $297.28 M(+1.1%) |
| Sept 2012 | - | $75.38 M(+4.5%) | $294.16 M(+4.2%) |
| June 2012 | - | $72.13 M(-2.4%) | $282.31 M(+5.4%) |
| Mar 2012 | - | $73.91 M(+1.6%) | $267.78 M(+7.2%) |
| Dec 2011 | $249.74 M(+11.0%) | $72.75 M(+14.5%) | $249.74 M(+5.2%) |
| Sept 2011 | - | $63.53 M(+10.3%) | $237.31 M(+1.7%) |
| June 2011 | - | $57.59 M(+3.1%) | $233.32 M(+1.7%) |
| Mar 2011 | - | $55.87 M(-7.4%) | $229.44 M(+2.0%) |
| Dec 2010 | $224.99 M(+20.5%) | $60.31 M(+1.3%) | $224.99 M(+7.7%) |
| Sept 2010 | - | $59.54 M(+10.8%) | $208.95 M(+7.9%) |
| June 2010 | - | $53.72 M(+4.5%) | $193.61 M(+1.1%) |
| Mar 2010 | - | $51.41 M(+16.1%) | $191.58 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $186.78 M(-11.0%) | $44.28 M(+0.2%) | $186.78 M(-5.7%) |
| Sept 2009 | - | $44.20 M(-14.5%) | $198.03 M(-5.2%) |
| June 2009 | - | $51.69 M(+10.9%) | $208.90 M(-1.6%) |
| Mar 2009 | - | $46.62 M(-16.0%) | $212.31 M(+1.1%) |
| Dec 2008 | $209.88 M(+14.2%) | $55.53 M(+0.8%) | $210.06 M(-1.8%) |
| Sept 2008 | - | $55.07 M(-0.0%) | $213.81 M(+4.5%) |
| June 2008 | - | $55.10 M(+24.2%) | $204.69 M(+6.9%) |
| Mar 2008 | - | $44.37 M(-25.1%) | $191.50 M(+4.2%) |
| Dec 2007 | $183.85 M(+48.8%) | $59.27 M(+29.0%) | $183.85 M(+14.0%) |
| Sept 2007 | - | $45.96 M(+9.7%) | $161.34 M(+8.2%) |
| June 2007 | - | $41.90 M(+14.1%) | $149.17 M(+7.8%) |
| Mar 2007 | - | $36.72 M(-0.1%) | $138.43 M(+9.8%) |
| Dec 2006 | $123.56 M(+102.8%) | $36.76 M(+8.8%) | $126.10 M(+19.0%) |
| Sept 2006 | - | $33.79 M(+8.4%) | $105.94 M(+22.8%) |
| June 2006 | - | $31.16 M(+27.8%) | $86.28 M(+21.0%) |
| Mar 2006 | - | $24.39 M(+46.9%) | $71.29 M(+17.0%) |
| Dec 2005 | $60.93 M(+31.0%) | $16.60 M(+17.4%) | $60.93 M(+2.7%) |
| Sept 2005 | - | $14.14 M(-12.5%) | $59.31 M(+1.3%) |
| June 2005 | - | $16.16 M(+15.2%) | $58.54 M(+14.6%) |
| Mar 2005 | - | $14.03 M(-6.4%) | $51.08 M(+9.4%) |
| Dec 2004 | $46.51 M(+29.5%) | $14.98 M(+12.1%) | $46.71 M(+6.9%) |
| Sept 2004 | - | $13.37 M(+53.5%) | $43.70 M(+2.7%) |
| June 2004 | - | $8.71 M(-9.8%) | $42.57 M(+1.5%) |
| Mar 2004 | - | $9.65 M(-19.4%) | $41.95 M(+16.2%) |
| Dec 2003 | $35.92 M(+56.3%) | $11.98 M(-2.1%) | $36.11 M(+8.2%) |
| Sept 2003 | - | $12.23 M(+51.1%) | $33.38 M(+17.5%) |
| June 2003 | - | $8.09 M(+112.4%) | $28.40 M(+3.1%) |
| Mar 2003 | - | $3.81 M(-58.8%) | $27.54 M(-9.5%) |
| Dec 2002 | $22.98 M(-41.9%) | $9.24 M(+27.3%) | $30.45 M(+29.1%) |
| Sept 2002 | - | $7.26 M(+0.3%) | $23.59 M(-23.6%) |
| June 2002 | - | $7.23 M(+7.8%) | $30.85 M(-12.8%) |
| Mar 2002 | - | $6.71 M(+181.7%) | $35.40 M(-10.5%) |
| Dec 2001 | $39.55 M(+15.0%) | $2.38 M(-83.6%) | $39.55 M(-19.3%) |
| Sept 2001 | - | $14.52 M(+23.3%) | $48.99 M(+10.5%) |
| June 2001 | - | $11.78 M(+8.4%) | $44.32 M(+10.7%) |
| Mar 2001 | - | $10.87 M(-8.1%) | $40.02 M(+16.1%) |
| Dec 2000 | $34.39 M(+80.6%) | $11.82 M(+20.0%) | $34.47 M(+35.8%) |
| Sept 2000 | - | $9.85 M(+31.7%) | $25.39 M(-1.0%) |
| June 2000 | - | $7.48 M(+40.6%) | $25.64 M(+13.9%) |
| Mar 2000 | - | $5.32 M(+93.9%) | $22.50 M(+19.2%) |
| Dec 1999 | $19.04 M(-49.4%) | $2.74 M(-72.9%) | $18.87 M(-16.3%) |
| Sept 1999 | - | $10.10 M(+132.5%) | $22.55 M(-15.7%) |
| June 1999 | - | $4.34 M(+157.3%) | $26.75 M(-18.5%) |
| Mar 1999 | - | $1.69 M(-73.7%) | $32.81 M(-13.3%) |
| Dec 1998 | $37.62 M(+24.6%) | $6.42 M(-55.1%) | $37.82 M(-13.1%) |
| Sept 1998 | - | $14.30 M(+37.5%) | $43.50 M(+15.7%) |
| June 1998 | - | $10.40 M(+55.2%) | $37.60 M(+10.9%) |
| Mar 1998 | - | $6.70 M(-44.6%) | $33.90 M(+11.9%) |
| Dec 1997 | $30.20 M(+141.6%) | $12.10 M(+44.0%) | $30.30 M(+39.6%) |
| Sept 1997 | - | $8.40 M(+25.4%) | $21.70 M(+30.7%) |
| June 1997 | - | $6.70 M(+116.1%) | $16.60 M(+27.7%) |
| Mar 1997 | - | $3.10 M(-11.4%) | $13.00 M(+2.4%) |
| Dec 1996 | $12.50 M(+23.8%) | $3.50 M(+6.1%) | $12.70 M(+6.7%) |
| Sept 1996 | - | $3.30 M(+6.5%) | $11.90 M(+6.3%) |
| June 1996 | - | $3.10 M(+10.7%) | $11.20 M(-58.1%) |
| Mar 1996 | - | $2.80 M(+3.7%) | $26.70 M(-36.0%) |
| Dec 1995 | $10.10 M | $2.70 M(+3.8%) | $41.70 M(+6.9%) |
| Sept 1995 | - | $2.60 M(-86.0%) | $39.00 M(+7.1%) |
| June 1995 | - | $18.60 M(+4.5%) | $36.40 M(+104.5%) |
| Mar 1995 | - | $17.80 M | $17.80 M |
FAQ
- What is Core Laboratories NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for Core Laboratories NV?
- What is Core Laboratories NV annual EBIT year-on-year change?
- What is Core Laboratories NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Core Laboratories NV?
- What is Core Laboratories NV quarterly EBIT year-on-year change?
- What is Core Laboratories NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Core Laboratories NV?
- What is Core Laboratories NV TTM EBIT year-on-year change?
What is Core Laboratories NV annual earnings before interest & taxes?
The current annual EBIT of CLB is $54.64 M
What is the all time high annual EBIT for Core Laboratories NV?
Core Laboratories NV all-time high annual earnings before interest & taxes is $373.23 M
What is Core Laboratories NV annual EBIT year-on-year change?
Over the past year, CLB annual earnings before interest & taxes has changed by +$13.12 M (+31.59%)
What is Core Laboratories NV quarterly earnings before interest & taxes?
The current quarterly EBIT of CLB is $19.80 M
What is the all time high quarterly EBIT for Core Laboratories NV?
Core Laboratories NV all-time high quarterly earnings before interest & taxes is $90.45 M
What is Core Laboratories NV quarterly EBIT year-on-year change?
Over the past year, CLB quarterly earnings before interest & taxes has changed by +$5.13 M (+34.97%)
What is Core Laboratories NV TTM earnings before interest & taxes?
The current TTM EBIT of CLB is $58.96 M
What is the all time high TTM EBIT for Core Laboratories NV?
Core Laboratories NV all-time high TTM earnings before interest & taxes is $346.53 M
What is Core Laboratories NV TTM EBIT year-on-year change?
Over the past year, CLB TTM earnings before interest & taxes has changed by +$3.29 M (+5.90%)